bretylium tosylate has been researched along with Arrhythmia in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (93.55) | 18.7374 |
| 1990's | 2 (6.45) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DiBianco, R; Fletcher, RD; Gottdiener, JS | 1 |
| Boike, SC; Rybak, MJ | 1 |
| DePace, NL; Morganroth, J; Nestico, PF | 1 |
| Torresani, J | 1 |
| Mayer, NM | 1 |
| Berre, J; Dufaye, P; Kahn, RJ; Vincent, JL | 1 |
| Kron, IL; Nolan, SP | 1 |
| Sullivan, HE; Wehner, RJ | 1 |
| Baskin, SI; Gerard-Ciminera, JL; Kelliher, GJ; Krusz, JC; Lathers, CM; Roberts, J | 1 |
| Harrison, DC; Kates, RE; Keefe, DL | 1 |
| Bacaner, MB; Benditt, DG | 1 |
| Lucchesi, BR; Patterson, E | 1 |
| Nies, AS; Oates, JA; Reele, SB; Roden, DM; Woosley, RL | 1 |
| Gibson, JK; Patterson, E | 1 |
| Binnion, PF; Das Gupta, R | 1 |
| Condouris, GA; Lyness, W; Ortiz, J | 1 |
| Bigger, JT; Heissenbuttel, RH | 1 |
| Bryan, CK; Darby, MH | 1 |
| Assmann, I; Fiehring, H; Steffen, V | 1 |
| Fiehring, H; Steffen, V | 1 |
| Alcaraz, C; Delaney, KA; Goldfrank, LR; Orts, A; Puig, MM; Turndorf, H | 1 |
| DeBehnke, DJ | 1 |
| Kabell, G | 1 |
| Doherty, JE | 1 |
| Somberg, J | 1 |
| Huang, SK; Marcus, FI | 1 |
| Davy, JM; Dorian, P; Fain, ES; Winkle, RA | 1 |
| Anderson, JL | 1 |
| Duff, HJ; Maffucci, RJ; Oates, JA; Robertson, D; Roden, DM; Wang, T; Woosley, RL; Yacobi, A | 1 |
12 review(s) available for bretylium tosylate and Arrhythmia
| Article | Year |
|---|---|
Effects of antiarrhythmic agents on cardiac function.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Dogs; Encainide; Hemodynamics; Humans; Myocardial Contraction; Quinidine; Verapamil | 1982 |
Pharmacologic interventions in resuscitation.
Topics: Adrenal Cortex Hormones; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Bretylium Tosylate; Calcium Channel Blockers; Cardiotonic Agents; Dobutamine; Dopamine; Heart Arrest; Humans; Isoproterenol; Lidocaine; Naloxone; Norepinephrine; Resuscitation; Vasoconstrictor Agents | 1983 |
Therapy with conventional antiarrhythmic drugs for ventricular arrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Heart Ventricles; Humans; Lidocaine; Procainamide; Propranolol; Quinidine; Tocainide | 1984 |
New antiarrhythmic drugs: their place in therapy.
Topics: Action Potentials; Ajmaline; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Tosylate; Disopyramide; Encainide; Hemodynamics; Humans; Kinetics; Moricizine; Morpholines; Phenothiazines; Piperidines; Verapamil | 1981 |
Prophylactic antiarrhythmic drug therapy in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Bretylium Tosylate; Humans; Lidocaine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine | 1975 |
Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias.
Topics: Action Potentials; Adrenergic Fibers; Animals; Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Drug Evaluation; Drug Interactions; Drug Resistance; Heart Conduction System; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Myocardial Contraction; Myocardial Infarction; Pharmaceutical Vehicles; Purkinje Fibers; Quinidine; Sympathetic Nervous System; Tachycardia; Ventricular Fibrillation | 1979 |
Bretylium tosylate: a review.
Topics: Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Drug Interactions; Humans; Kinetics; Monitoring, Physiologic | 1979 |
[Bretylium tosylate as an anti-arrhythmic drug].
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Bretylium Compounds; Bretylium Tosylate; Digitalis Glycosides; Dose-Response Relationship, Drug; Drug Incompatibility; Heart Rate; Humans; Hypotension; Quinidine; Stimulation, Chemical; Vascular Resistance | 1976 |
Clinical use of digitalis glycosides. An update.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Age Factors; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Biological Availability; Bretylium Tosylate; Deslanoside; Digitalis Glycosides; Digitoxin; Digoxin; Dose-Response Relationship, Drug; Drug Interactions; Heart Failure; Humans; Injections, Intramuscular; Injections, Intravenous; Intestinal Absorption; Kidney Failure, Chronic; Lidocaine; Metabolic Clearance Rate; Myocardial Infarction; Obesity; Phenytoin; Potassium; Pulmonary Heart Disease; Thyroid Diseases | 1985 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Chemical Phenomena; Chemistry; Coronary Disease; Dogs; Drug Implants; Electrophysiology; Heart Arrest; Hemodynamics; Humans; Injections, Intramuscular; Injections, Intravenous; Kinetics; Myocardial Infarction; Postoperative Complications; Tachycardia | 1985 |
2 trial(s) available for bretylium tosylate and Arrhythmia
| Article | Year |
|---|---|
[Clinical experiences with bretylium tosylate].
Topics: Adult; Aged; Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Clinical Trials as Topic; Drug Evaluation; Drug Tolerance; Female; Hemodynamics; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged | 1976 |
Bretylium: relations between plasma concentrations and pharmacologic actions in high-frequency ventricular arrhythmias.
Topics: Adult; Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Electrocardiography; Heart Ventricles; Humans; Kinetics; Male; Middle Aged; Norepinephrine; Reflex; Sympathomimetics; Vasoconstriction | 1985 |
17 other study(ies) available for bretylium tosylate and Arrhythmia
| Article | Year |
|---|---|
Bretylium tosylate in patients with acute myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Hemodynamics; Humans; Hypotension; Myocardial Contraction; Myocardial Infarction; Ventricular Fibrillation | 1984 |
Management of ventricular dysrhythmias in the prehospital and emergency department setting.
Topics: Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Coronary Disease; Electric Countershock; Emergency Medical Services; Emergency Service, Hospital; Heart Ventricles; Hospitalization; Humans; Lidocaine; North Carolina; Procainamide; Resuscitation; Time Factors; Ventricular Fibrillation | 1984 |
Bretylium in severe ventricular arrhythmias associated with digitalis intoxication.
Topics: Aged; Arrhythmias, Cardiac; Blood Pressure; Bretylium Compounds; Bretylium Tosylate; Digoxin; Electric Countershock; Electrocardiography; Female; Heart Ventricles; Humans; Lidocaine; Male; Middle Aged; Suicide, Attempted | 1984 |
Severe hypotension due to the use of bretylium for postcardiotomy ventricular arrhythmias.
Topics: Adult; Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Cardiac Surgical Procedures; Coronary Artery Bypass; Female; Heart Ventricles; Humans; Hypotension; Male; Middle Aged; Postoperative Complications | 1983 |
Life threatening ventricular dysrhythmias: intervention with bretylium tosylate.
Topics: Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Heart Ventricles; Hemodynamics; Humans; Myocardial Contraction; Myocardial Infarction; Stimulation, Chemical | 1983 |
The action of reserpine, 6-hydroxydopamine, and bretylium on digitalis-induced cardiotoxicity.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Bretylium Compounds; Bretylium Tosylate; Cats; Digitalis Glycosides; Drug Interactions; Female; Heart Rate; Hydroxydopamines; Male; Ouabain; Oxidopamine; Reserpine | 1981 |
Antiarrhythmic, antifibrillatory, and hemodynamic actions of bethanidine sulfate: an orally effective analog of bretylium for suppression of ventricular tachyarrhythmias.
Topics: Adult; Aged; Arrhythmias, Cardiac; Bethanidine; Bretylium Tosylate; Depression, Chemical; Dose-Response Relationship, Drug; Electrophysiology; Female; Guanidines; Hemodynamics; Humans; Long-Term Care; Male; Middle Aged; Tachycardia; Ventricular Fibrillation | 1982 |
Bretylium: a prototype for future development of antidysrhythmic agents.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Bretylium Compounds; Bretylium Tosylate; Death, Sudden; Heart; Humans; Research | 1983 |
Pharmacologic reversal of hypotensive effect complicating antiarrhythmic therapy with bretylium.
Topics: Administration, Oral; Adrenergic Fibers; Adult; Aged; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Dibenzocycloheptenes; Electrocardiography; Humans; Hypotension, Orthostatic; Middle Aged; Protriptyline; Venous Pressure | 1982 |
Prevention of chronic canine ventricular tachyarrhythmias with bretylium tosylate.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Dogs; Electric Stimulation; Heart; Heart Ventricles; Male; Tachycardia | 1981 |
Cardiac arrhythmias produced by bretylium in cats anesthetized with halothane.
Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Blood Gas Analysis; Blood Pressure; Bretylium Compounds; Bretylium Tosylate; Cats; Drug Interactions; Electrocardiography; Female; Halothane; Heart Rate; Hydrogen-Ion Concentration; Male | 1979 |
Drugs used in the care of the cardiac patient.
Topics: Anticoagulants; Antihypertensive Agents; Arrhythmias, Cardiac; Atropine; Bretylium Tosylate; Cardiac Glycosides; Cardiovascular Diseases; Digitalis Glycosides; Disopyramide; Diuretics; Dose-Response Relationship, Drug; Humans; Isoproterenol; Lidocaine; Myocardial Contraction; Propranolol; Quinidine | 1978 |
Bretylium (Bretylol) for ventricular arrhythmias.
Topics: Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Electric Countershock; Heart Ventricles; Humans; Ventricular Fibrillation | 1978 |
Bretylium tosylate and electrically induced cardiac arrhythmias during hypothermia in dogs.
Topics: Animals; Arrhythmias, Cardiac; Bretylium Tosylate; Dogs; Dopamine; Electric Stimulation; Electrophysiology; Epinephrine; Heart; Hemodynamics; Hypothermia; Male; Norepinephrine | 1992 |
Effects of bretylium tosylate during experimental cardiac arrest.
Topics: Animals; Arrhythmias, Cardiac; Bretylium Tosylate; Heart Arrest; Resuscitation | 1991 |
Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Bethanidine; Bretylium Compounds; Bretylium Tosylate; Coronary Disease; Dogs; Guanidines; Heart Conduction System; Perfusion; Rabbits; Tachycardia; Time Factors; Ventricular Fibrillation | 1989 |
Effect of quinidine and bretylium on defibrillation energy requirements.
Topics: Animals; Arrhythmias, Cardiac; Bretylium Compounds; Bretylium Tosylate; Dogs; Electric Countershock; Models, Biological; Quinidine; Ventricular Fibrillation | 1986 |